共享决策策略在房颤患者卒中预防中的有效性:整群随机对照试验
在美国6家学术医学中心开展整群随机对照试验,纳入1117例有卒中风险的非瓣膜性房颤患者。患者随机使用患者决策辅助工具或常规照护,临床医生随机使用就诊决策辅助工具或常规照护。结果显示,联合使用两种决策辅助工具可改善共享决策质量、提高房颤及其管理知识并降低决策冲突,治疗选择和满意度无重要差异。
要点
- 联合使用患者决策辅助工具与就诊决策辅助工具可改善共享决策质量(校正均差12.1)。
- 联合使用两种决策辅助工具提高患者知识(OR 1.68)并降低决策冲突(校正均差-6.3)。
- 卒中预防治疗选择与满意度在各研究组间无重要差异,就诊时长无统计学显著差异。
核心结论
- 接受任何决策辅助工具(就诊决策辅助工具、患者决策辅助工具或两者)的患者较未接受决策辅助工具者决策冲突更低、共享决策更好、知识更多,但患者决策辅助工具对决策冲突的影响未达统计学显著。
- 研究确立就诊前或就诊中使用决策辅助工具,单独或联合使用,均优于常规照护。
研究设计与样本
- 整群随机对照试验,在美国6家学术医学中心开展。
- 患者参与者年龄≥18岁,诊断为非瓣膜性房颤,有卒中风险(男性CHA2DS2-VASc≥1,女性≥2),并已预约讨论卒中预防策略的临床就诊。
- 参与临床医生为管理参与患者卒中预防策略的医生。
- 患者随机使用患者决策辅助工具或常规照护;临床医生随机使用就诊决策辅助工具或常规照护,适用于所有参与患者。
- 分析共纳入6个中心的1117名参与者。
主要发现
- 与常规照护相比,联合使用患者决策辅助工具和就诊决策辅助工具改善共享决策质量(校正均差12.1,95%CI 8.0至16.2;P<0.001)。
- 联合使用两种决策辅助工具提高患者知识(OR 1.68,95%CI 1.35至2.09;P<0.001)。
- 联合使用两种决策辅助工具降低患者决策冲突(校正均差-6.3,95%CI -9.6至-3.1;P<0.001)。
- 单用就诊决策辅助工具与常规照护相比,三项结局均观察到统计学显著改善;单用患者决策辅助工具与常规照护相比,共享决策质量和知识观察到统计学显著改善。
- 卒中预防治疗选择或参与者满意度未观察到重要差异;各研究组间就诊时长未检测到统计学显著差异。
关键数值与推荐
- 共享决策质量采用OPTION12测量,联合使用两种决策辅助工具较常规照护校正均差12.1(95%CI 8.0至16.2;P<0.001)。
- 房颤及其管理知识:联合使用两种决策辅助工具较常规照护OR 1.68(95%CI 1.35至2.09;P<0.001)。
- 决策冲突:联合使用两种决策辅助工具较常规照护校正均差-6.3(95%CI -9.6至-3.1;P<0.001)。
- 患者决策辅助工具对决策冲突的影响未达统计学显著。
- 卒中预防治疗选择与参与者满意度在各研究组间无重要差异,就诊时长无统计学显著差异。
临床怎么用
- 作者认为,就诊前或就诊中单独或联合使用决策辅助工具均优于常规照护。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effectiveness of multiple decision aid strategies in promoting high quality shared decision making for prevention of stroke in patients with non-valvular atrial fibrillation. DESIGN: Cluster randomized controlled trial. SETTING: Six academic medical centers in the United States. PARTICIPANTS: Patient participants were aged ≥18 with a diagnosis of non-valvular atrial fibrillation, at risk for stroke (CHA2DS2-VASc ≥1 for men, ≥2 for women), and scheduled for a clinical appointment to discuss stroke prevention strategies. Participating clinicians were those who manage stroke prevention strategies for participating patients. INTERVENTION: Patients were randomized to use a patient decision aid or usual care; clinicians were randomized to use an encounter decision aid or usual care with all participating patients. MAIN OUTCOME MEASURES: Primary outcome measures were quality of shared decision making measured by OPTION12, knowledge of atrial fibrillation and its management, and decisional conflict. RESULTS: 1117 participants across six sites were included in the analysis. Compared with usual care, the combined use of both the patient decision aid and the encounter decision aid improved the quality of shared decision making (adjusted mean difference 12.1 (95% confidence interval (CI) 8.0 to 16.2; P<0.001), improved patients' knowledge (odds ratio 1.68 (95% CI 1.35 to 2.09; P<0.001), and reduced patients' decisional conflict (adjusted mean difference -6.3 (95% CI -9.6 to -3.1; P<0.001). Statistically significant improvements were also observed with the encounter decision aid alone versus usual care for all three outcomes and with the patient decision aid alone versus usual care for quality of shared decision making and knowledge. No important differences were observed in treatment choices for stroke prevention or in participants' satisfaction. No statistically significant difference in the length of visit across study groups was detected. CONCLUSION: Patients who received any decision aid (encounter decision aid, patient decision aid, or both) had lower decisional conflict, better shared decision making, and greater knowledge than those receiving no decision aid, except for the effect of the patient decision aid on decisional conflict, which did not reach statistical significance. The study establishes that use of either pre-visit or in-visit decision aids individually or in combination is advantageous compared with usual care. TRIAL REGISTRATION: ClinicalTrials.gov NCT04357288.
引用
- Ozanne EM, Barnes GD, Brito JP, et al. Effectiveness of shared decision making strategies for stroke prevention among patients with atrial fibrillation: cluster randomized controlled trial. BMJ. 2025. PMID: 39788611. doi:10.1136/bmj-2024-079976
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。